Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ingelsson

Showing results (71-80 of 217) with videos related to

Pageof 22
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's diseaseBodil Weidung, Eva-Stina Hemmingsson, Jan Olsson, et al.
Plos One|November 11, 2011
Antibodies against alpha-synuclein reduce oligomerization in living cellsThomas Näsström, Susana Gonçalves, Charlotte Sahlin, et al.
Plos One|May 9, 2014
Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer's diseaseGabriel Westman, David Berglund, Johan Widén, et al.
Pharmaceutics|July 27, 2022
Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific AntibodySahar Roshanbin, Ulrika Julku, Mengfei Xiong, et al.
Molecular and Cellular Neurosciences|April 29, 2017
Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damageVeronica Lindström, Gabriel Gustafsson, Laurie H Sanders, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's diseaseYoshiaki Sato, Francois Bernier, Yasukazu Yamanaka, et al.
Free Radical Biology & Medicine|December 7, 2010
The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional propertiesThomas Näsström, Therese Fagerqvist, Mikael Barbu, et al.
Molecular Psychiatry|June 26, 2020
Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9Laetitia Lemoine, Per-Göran Gillberg, Nenad Bogdanovic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsAlia Alokley, Juan-Camilo Vargas-González, Hessah A Alotibi, et al.
BMC Geriatrics|July 31, 2020
Dual-task tests discriminate between dementia, mild cognitive impairment, subjective cognitive impairment, and healthy controls - a cross-sectional cohort studyHanna B Åhman, Ylva Cedervall, Lena Kilander, et al.
Pageof 22

Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's diseaseBodil Weidung, Eva-Stina Hemmingsson, Jan Olsson, et al.
Plos One|November 11, 2011
Antibodies against alpha-synuclein reduce oligomerization in living cellsThomas Näsström, Susana Gonçalves, Charlotte Sahlin, et al.
Plos One|May 9, 2014
Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer's diseaseGabriel Westman, David Berglund, Johan Widén, et al.
Pharmaceutics|July 27, 2022
Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific AntibodySahar Roshanbin, Ulrika Julku, Mengfei Xiong, et al.
Molecular and Cellular Neurosciences|April 29, 2017
Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damageVeronica Lindström, Gabriel Gustafsson, Laurie H Sanders, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's diseaseYoshiaki Sato, Francois Bernier, Yasukazu Yamanaka, et al.
Free Radical Biology & Medicine|December 7, 2010
The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional propertiesThomas Näsström, Therese Fagerqvist, Mikael Barbu, et al.
Molecular Psychiatry|June 26, 2020
Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9Laetitia Lemoine, Per-Göran Gillberg, Nenad Bogdanovic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsAlia Alokley, Juan-Camilo Vargas-González, Hessah A Alotibi, et al.
BMC Geriatrics|July 31, 2020
Dual-task tests discriminate between dementia, mild cognitive impairment, subjective cognitive impairment, and healthy controls - a cross-sectional cohort studyHanna B Åhman, Ylva Cedervall, Lena Kilander, et al.
Pageof 22